Henk Jan Out
Henk Jan Out
University of Sunderland, United Kingdom
Geverifieerd e-mailadres voor sunderland.ac.uk - Homepage
Geciteerd door
Geciteerd door
The “primary” antiphospholipid syndrome: major clinical and serological features
Medicine 68 (6), 366-374, 1989
Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies
HJ Out, CD Kooijman, HW Bruinse, RHWM Derksen
European Journal of Obstetrics & Gynecology and Reproductive Biology 41 (3 …, 1991
A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization
HJ Out, BMJL Mannaerts, SGAJ Driessen, HJT Coelingh Bennink
Human Reproduction 10 (10), 2534-2540, 1995
A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies
HJ Out, HW Bruinse, GCML Christiaens, M van Vliet, PG de Groot, ...
American journal of obstetrics and gynecology 167 (1), 26-32, 1992
Recombinant follicle-stimulating hormone (FSH; Puregon) is more efficient than urinary FSH (Metrodin) in women with clomiphene citrate-resistant, normogonadotropic, chronic …
HJTC Bennink, BCJM Fauser, HJ Out, ...
Fertility and Sterility 69 (1), 19-25, 1998
Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins
HJ Out, SGAJ Driessen, BMJL Mannaerts, HJTC Bennink
Fertility and sterility 68 (1), 138-142, 1997
Recombinant follicle stimulating hormone (rFSH; Puregon) in assisted reproduction: more oocytes, more pregnancies. Results from five comparative studies
HJ Out, BMJL Mannaerts, SGAJ Driessen, HJTC Bennink
Human reproduction update 2 (2), 162-171, 1996
Increasing the daily dose of recombinant follicle stimulating hormone (Puregon®) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation
HJ Out, DDM Braat, BME Lintsen, T Gurgan, O Bukulmez, O Gökmen, ...
Human Reproduction 15 (1), 29-35, 2000
Prevalence of antiphospholipid antibodies in patients with fetal loss.
HJ Out, HW Bruinse, GC Christiaens, M Van Vliet, JF Meilof, PG De Groot, ...
Annals of the rheumatic diseases 50 (8), 553-557, 1991
Antibodies to platelets in patients with anti-phospholipid antibodies
HJ Out, PG de Groot, M van Vliet, GC de Gast, HK Nieuwenhuis, ...
Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study.
HJ Out, PG de Groot, P Hasselaar, M dan Vliet, RH Derksen
Annals of the rheumatic diseases 48 (12), 1023-1028, 1989
Efficacy and safety of recombinant follicle stimulating hormone (Puregon®) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization: a …
B Hedon, HJ Out, JN Hugues, B Camier, J Cohen, P Lopes, JR Zorn, ...
Human Reproduction 10 (12), 3102-3106, 1995
Clinical profiling of recombinant follicle stimulating hormone (rFSH; Puregon): relationship between serum FSH and efficacy
BMJL Mannaerts, F Rombout, HJ Out, HC Bennink
Human reproduction update 2 (2), 153-161, 1996
Role of editorial and peer review processes in publication bias: analysis of drug trials submitted to eight medical journals
M van Lent, J Overbeke, HJ Out
PloS one 9 (8), e104846, 2014
A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon®) in women …
HJ Out, S Lindenberg, AL Mikkelsen, T Eldar-Geva, DL Healy, A Leader, ...
Human Reproduction 14 (3), 622-627, 1999
A randomized, double-blind clinical trial using fixed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles
HJ Out, I David, R Ron-El, S Friedler, E Shalev, J Geslevich, J Dor, ...
Human Reproduction 16 (6), 1104-1109, 2001
A randomized, double‐blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for …
HJ Out, A Rutherford, R Fleming, CCK Tay, G Trew, W Ledger, D Cahill
Human Reproduction 19 (1), 90-95, 2004
The cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatments
D Sykes, HJ Out, SJ Palmer, J Loon
Human Reproduction 16 (12), 2557-2562, 2001
A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in …
CA Jansen, HC van Os, HJ Out, HJ Coelingh Bennink
Human reproduction (Oxford, England) 13 (11), 2995-2999, 1998
Drug delivery system
RJJ Groenewegen, W De Graaff, HJ Out
US Patent 8,333,983, 2012
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20